On Monday, Rocket Pharmaceuticals Inc (NASDAQ: RCKT) opened lower -6.98% from the last session, before settling in for the closing price of $9.45. Price fluctuations for RCKT have ranged from $8.94 to $31.24 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 19.66% at the time writing. With a float of $98.95 million, this company’s outstanding shares have now reached $106.45 million.
The firm has a total of 299 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Rocket Pharmaceuticals Inc (RCKT) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Rocket Pharmaceuticals Inc is 7.20%, while institutional ownership is 101.13%. The most recent insider transaction that took place on Feb 25 ’25, was worth 69,109. In this transaction an insider of this company sold 6,532 shares at a rate of $10.58, taking the stock ownership to the 237,638 shares. Before that another transaction happened on May 17 ’24, when Company’s insider sold 2,754 for $23.35, making the entire transaction worth $64,306. This insider now owns 169,659 shares in total.
Rocket Pharmaceuticals Inc (RCKT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.62 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 19.66% per share during the next fiscal year.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Trading Performance Indicators
Check out the current performance indicators for Rocket Pharmaceuticals Inc (RCKT). In the past quarter, the stock posted a quick ratio of 9.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.73, a number that is poised to hit -0.61 in the next quarter and is forecasted to reach -1.57 in one year’s time.
Technical Analysis of Rocket Pharmaceuticals Inc (RCKT)
Analysing the last 5-days average volume posted by the [Rocket Pharmaceuticals Inc, RCKT], we can find that recorded value of 1.52 million was better than the volume posted last year of 1.44 million. As of the previous 9 days, the stock’s Stochastic %D was 11.15%. Additionally, its Average True Range was 0.61.
During the past 100 days, Rocket Pharmaceuticals Inc’s (RCKT) raw stochastic average was set at 0.10%, which indicates a significant decrease from 0.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 53.18% in the past 14 days, which was higher than the 51.58% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.86, while its 200-day Moving Average is $17.05. Now, the first resistance to watch is $9.21. This is followed by the second major resistance level at $9.64. The third major resistance level sits at $9.85. If the price goes on to break the first support level at $8.57, it is likely to go to the next support level at $8.36. Should the price break the second support level, the third support level stands at $7.93.
Rocket Pharmaceuticals Inc (NASDAQ: RCKT) Key Stats
There are currently 91,157K shares outstanding in the company with a market cap of 937.27 million. Presently, the company’s annual sales total 0 K according to its annual income of -245,600 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -66,720 K.
